- Home
- FLUX vs PSTV Comparison
FLUX vs PSTV Comparison
Compare FLUX & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLUX | PSTV |
|---|---|---|
| Founded | N/A | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.3M | 27.9M |
| IPO Year | 2019 | 2016 |
Fundamental Metrics
Financial Performance| Metric | FLUX | PSTV |
|---|---|---|
| Price | $1.05 | $6.15 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $55.00 |
| AVG Volume (30 Days) | 142.3K | ★ 252.6K |
| Earning Date | 05-07-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 20.00 | ★ 87.61 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $9,317,000.00 | $5,213,000.00 |
| Revenue This Year | N/A | $13.20 |
| Revenue Next Year | $23.01 | $261.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 126.25 | N/A |
| 52 Week Low | $0.91 | $0.13 |
| 52 Week High | $7.55 | $8.00 |
Technical Indicators
Market Signals| Indicator | FLUX | PSTV |
|---|---|---|
| Relative Strength Index (RSI) | 35.60 | 60.66 |
| Support Level | $1.01 | $0.37 |
| Resistance Level | $1.20 | $6.65 |
| Average True Range (ATR) | 0.08 | 0.59 |
| MACD | -0.02 | -0.25 |
| Stochastic Oscillator | 24.43 | 20.40 |
Price Performance
Historical ComparisonAbout FLUX Flux Power Holdings Inc.
Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, commercializing and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).